MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'flumist'. Sat, 03 Sep 2011 02:22:00 +0100 http://www.medworm.com/index.php?rid=4501583&cid=t_147996_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Ftheres-still-time-for-a-flu-shot%2F2011.02.21 It’s not too late to protect yourself and your family from the flu. Influenza is about to enter its peak season in the United States. Now is the time to be vigilant in protecting against and preventing the spread of flu. Washing your hands, staying home from work or school, and covering your cough can be incredible steps. But the most effective way to prevent influenza is to get vaccinated. If you haven’t had a flu shot, get one this week. Your child can be immunized if over six months of age, and remember that many children under age nine will need a second dose (booster shot). Find out how to determine if your child needs a second dose. 1o Things To Know About Influenza 1. Influenza peaks in February and March in the United States. Look at the CDC data that reflects ongoing in... Better Health blogs http://www.medworm.com/rss/comments.php?id=4501583 Mon, 21 Feb 2011 18:00:38 +0100 4501583 http://www.medworm.com/index.php?rid=3925085&cid=t_147996_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXW-OHW3ZCaI%2F In a lawsuit filed in federal court in Philadelphia, the US Securities and Exchange Commission has charged Jim Self, a pharmaceutical executive, and Stephen Goldfield, a hedge fund manager, with insider trading in connection with the 2007 acquisiton of MedImmune by AstraZeneca. Ultimately, Goldfield made nearly $14 million on his trades, according to the lawsuit. The men allegedly met while attending the Executive MBA program at the Wharton School of Business in the mid-1990’s and, in March 2007, Self exec passed along confidential info about MedImmune. At the time, investment bankers were shopping the biotech to 22 drugmakers and Self had been assigned to evaluate a potential acquisition, according to the lawsuit. In fact, Self was “involved in practically all of the meetings&... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3925085 Wed, 01 Sep 2010 17:38:23 +0100 3925085 http://www.medworm.com/index.php?rid=3016926&cid=t_147996_139_f&fid=38879&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FqQsjBjTd9LQ%2F The suggestion that yearly immunization against influenza might make children more susceptible to serious disease during a pandemic has generated some controversy. Does this idea have merit? If you have read “Being older is a good defense against 2009 H1N1 influenza”, you are familiar with the concept of ‘heterosubtypic immunity’. After natural infection with influenza virus, the host produces T and B cells directed against internal proteins of the virions. These viral proteins are more conserved among different strains than the surface glycoproteins HA and NA. Upon infection with a different subtype – which occurs during a pandemic – heterosubtypic immunity could limit virus replication and reduce disease and death. Evidence for heterosubtypic immunity to influenza vir... virology blog blogs http://www.medworm.com/rss/comments.php?id=3016926 Fri, 06 Nov 2009 13:00:22 +0100 3016926 http://www.medworm.com/index.php?rid=3016935&cid=t_147996_139_f&fid=38879&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FaU1wBkg6Y00%2F There have been many interesting responses to my recent post, “Are you receiving the influenza 2009 H1N1 vaccine?” Some individuals have already been immunized or plan to do so shortly. Others are concerned about the safety and efficacy of the monovalent preparations. As pointed out recently in a Nature editorial, “Mass-vaccination campaigns…must take public concerns into account”, and “officials should focus on providing people with the information they need to make good choices for themselves.” Here are some facts about the influenza H1N1 vaccine for those who haven’t yet made up their minds whether or not to be immunized. Four companies are licensed to produce the 2009 H1N1 influenza vaccine for the US – CSL Limited, Novartis Vaccine... virology blog blogs http://www.medworm.com/rss/comments.php?id=3016935 Tue, 20 Oct 2009 12:00:39 +0100 3016935 http://www.medworm.com/index.php?rid=2855667&cid=t_147996_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FmGuXEn8fmQ4%2F If you’ve been waiting for the H1N1 (swine flu) nasal flu vaccine, FluMist, it will be available next week in some parts of the United States, but in limited quantities as this is the first shipment. Different states have different strategies for who will be the first to be vaccinated, either by FluMist or the traditional injection. Some states, such as Illinois want to vaccinate their first responders, while others, such as Alaska, want to vaccinate the preschoolers first. Pennsylvania will be targeting it’s elementary school-age children first. The FluMist isn’t for everyone. Because it contains a weakened live virus, it is not for people with health problems, but for healthy people who are in high risk groups. Those who are chronically ill must wait for the injection, ... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2855667 Fri, 02 Oct 2009 12:08:07 +0100 2855667 http://www.medworm.com/index.php?rid=2726967&cid=t_147996_139_f&fid=38879&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2Fp7SovphIZeY%2F A new type of vaccine against influenza, made with virus-like particles, has been shown to protect ferrets from infection with the 2009 H1N1 swine-origin strain. What is a virus-like particle, and how is it produced? If you have been taking influenza 101, you know that new virus particles are produced in infected cells by budding. During this process, the membrane bulges from the cell and is eventually pinched off to form a free particle. These virus particles contain the viral RNA segments, and an assortment of viral proteins including PA, PB1, PB2, NP, M1, M2, HA, and NA. But not all of those viral proteins are needed to produce an influenza virus particle. When only the viral HA, NA, and M1 proteins are synthesized in cells, particles are released from cells that look very much like in... virology blog blogs http://www.medworm.com/rss/comments.php?id=2726967 Wed, 19 Aug 2009 14:03:47 +0100 2726967 http://www.medworm.com/index.php?rid=2741087&cid=t_147996_139_f&fid=38879&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FkmedLUVeABE%2F The antibody response is crucial for preventing many viral infections and may also contribute to resolution of infection. When a vertebrate is infected with a virus, antibodies are produced against many epitopes on multiple virus proteins. A subset of these antibodies can block virus infection by a process that is called neutralization. Antibodies can neutralize viral infectivity in a number of ways, as summarized in the illustration. They may interfere with virion binding to receptors, block uptake into cells, prevent uncoating of the genomes in endosomes, or cause aggregation of virus particles. Many enveloped viruses are lysed when antiviral antibodies and serum complement disrupt membranes. Non-neutralizing antibodies are also produced after viral infection. Such antibodies bind ... virology blog blogs http://www.medworm.com/rss/comments.php?id=2741087 Fri, 24 Jul 2009 13:00:28 +0100 2741087 http://www.medworm.com/index.php?rid=1577358&cid=t_147996_133_f&fid=35096&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F326773354%2F Last Sunday a group of experts on mitochondrial disorders met for a meeting in Indianapolis to discuss the case of Hannah Poling, whose underlying mitochondrial disorder was found to have been aggravated by vaccines, after which she developed symptoms of autism. A June 30th New York Times article announced the meeting and noted the case of Hannah Poling and of a 6-year-old Colorado girl who also had a mitochondrial disorder and who, after receiving the FluMist vaccine, had to be hospitalized and died. Both the NYTimes article and an ABC News report did not make it sufficiently clear that the 6-year-old girl did not have autism. A July 4th story in the Commercial-News (Danville, IL) reports on the Indianapolis meeting, and almost makes it seem that the Colorado child had autism, as she did ... Autism Vox blogs http://www.medworm.com/rss/comments.php?id=1577358 Fri, 04 Jul 2008 16:51:40 +0100 1577358 http://www.medworm.com/index.php?rid=1554569&cid=t_147996_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F322591983%2F The Centers for Disease Control and Prevention is holding a meeting today with leading experts on an mitochondrial disorders to discuss the controversial case of a 9-year-old girl from Athens, Georgia, who became autistic after receiving numerous vaccinations, The New York Times reports. But, the paper writes, the government has so far kept quiet about a second case that some say is more disturbing and more relevant to the meeting. On Jan. 11, a 6-year-old girl from Colorado received the FluMist vaccine and about a week later “became weak with multiple episodes of falling to ground” and “difficulty walking,” according to a case report filed with federal health officials and obtained by the Times. The girl grew increasingly weak and feverish and “became more limp, appears sleepy,... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1554569 Sun, 29 Jun 2008 14:05:22 +0100 1554569 http://www.medworm.com/index.php?rid=998972&cid=t_147996_107_f&fid=36585&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHighlightHealth%2F%7E3%2F178281647%2F This article was published on Highlight HEALTH. (Source: Highlight HEALTH) Highlight HEALTH blogs http://www.medworm.com/rss/comments.php?id=998972 Thu, 01 Nov 2007 16:30:21 +0100 998972 http://www.medworm.com/index.php?rid=979217&cid=t_147996_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F174988547%2Fflumist_now_recommended_for_ch.html The Advisory Committee on Immunization Practices (ACIP) is now recommending that FluMist for children in the 2 to 5 year old bracket. Previously, the nasal spray was only for children over the age of 5.FluMist, by MedImmune, is a nasal spray flu vaccine that is a substitute for the flu vaccine. Approved in 2003 for people between the ages of 5 and 49, the FDA has now approved it for use in children 2 - 5 as well.The Committee did not advocate for FluMist over traditional flu shots but merely approved it as an alternative for children who fear needles. The ACIP also approved that the government extend its coverage to include FluMist. This means those children who are eligible for Medicaid, Native American children, Alaskan Native children and some who don't have insurance will have... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=979217 Thu, 25 Oct 2007 19:15:01 +0100 979217 http://www.medworm.com/index.php?rid=886292&cid=t_147996_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F159005866%2Ffda_approves_flumist_for_child_1.html MedImmune Inc. announced that the FDA has now approved FluMist™ for use in children as young as 24 months. The expansion in age now allows for FluMist™ to be used on people from ages 2 - 59. FluMIst(TM) is an Intranasal Influenza Virus Vaccine that is approved for immunization against influenza A and B. A study of over 4,000 children between the ages of two and five saw a 54% decrease in cases of the flu in children who received FluMIst™ as opposed to those that received a traditional flu shot. FluMist differs from the traditional flu shot in that it consists of live, weakened viruses that help stimulate an immune response to influenza. Pedro Piedra, M.D., professor, Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine said &q... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=886292 Thu, 20 Sep 2007 13:56:37 +0100 886292 http://www.medworm.com/index.php?rid=885517&cid=t_147996_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F158591675%2F We are motoring along today. The transom is overflowing with interesting news of the world. While we prepare more items for your pleasure, here are a few to keep you occupied in the meantime. And if you haven’t already, please take our poll on whether clinical trial databases should be made available on the Internet. West Virginia Curtails Reporting Prescription Data to Drugmakers (Yahoo/AP) Allergan To Pay $370M For Esprit Pharma And Its Bladder Drug (Yahoo/Reuters) FluMist Approved For Children Two To Five Years Old (Yahoo/Reuters) Express Scripts Unit To Pay $10.5M Fine Over HGH (Yahoo/AP) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=885517 Wed, 19 Sep 2007 15:41:58 +0100 885517